SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
We examined the association between SGLT2i and AF in the Food an...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Benedetta Maria Bonora, Emanuel Raschi, Angelo Avogaro and Gian Paolo Fadini Tags: Original investigation Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Endocrinology | Food and Drug Administration (FDA) | Heart | Heart Failure | Sodium